Showing results (381-390 of 435) with videos related to
Sort By:
Pageof 44
JAMA Network Open|May 6, 2022
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital SystemKatlyn Nemani, Sharifa Z Williams, Mark Olfson, et al.Schizophrenia Research|June 19, 2018
Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?Jean-Pierre Lindenmayer, Anzalee Khan, Susan R McGurk, et al.Public Health Reports (Washington, D.C. : 1974)|September 26, 2001
The role of state public health agencies in genetics and disease prevention: results of a national surveyM A Piper, J M Lindenmayer, E J Lengerich, et al.Archives of General Psychiatry|January 7, 2003
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)Herbert Y Meltzer, Larry Alphs, Alan I Green, et al.Journal of Economic Entomology|April 14, 2020
Development of Binomial Sequential Sampling Plans for Sugarcane Aphid (Hemiptera: Aphididae) in Commercial Grain SorghumJessica C Lindenmayer, Kristopher L Giles, Norman C Elliott, et al.The Journal of Clinical Psychiatry|June 6, 2009
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior responseJean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M Kulkarni, et al.Schizophrenia Research|November 9, 2019
Cognitive remediation for schizophrenia: An expert working group white paper on core techniquesChristopher R Bowie, Morris D Bell, Joanna M Fiszdon, et al.Psychiatry Research|October 29, 2005
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorderMatthew J Hoptman, Jan Volavka, Elisabeth M Weiss, et al.Plos One|March 12, 2025
Policy decisions matter: Cessation of logging benefits 34 threatened species in Victoria, AustraliaKita R Ashman, Michelle Ward, Chris R Dickman, et al.Pharmacological Research|February 3, 2005
Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatmentVincenzo De Luca, John B Vincent, Daniel J Müller, et al.Pageof 44